Preclinical Data with KIT D816V Inhibitor Bezuclastinib (CGT9486) Demonstrates High Selectivity and Minimal Brain Penetrance
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1182/blood-2021-152770
其他信息:
出版社: American Society of Hematology
作者: Anna Guarnieri; Mark Chicarelli; Louann Cable; Karyn Bouhana; Francis Sullivan; Howard Ball; Jessica Sachs; Shannon Winski; John Robinson
全文下载地址: https://ashpublications.org/blood/article/138/Supplement%201/4595/478022/Preclinical-Data-with-KIT-D816V-Inhibitor